secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioXcel Therapeutics, Inc. (BTAI)
CIK:        0001720893
Form:       8-K
Filed at:   2026-08-03T11:00:23+00:00
Accession:  0001104659-26-089436
Event type: debt
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioXcel defers $9M payment to Aug 31, cuts liquidity covenant to $6.25M
-----------------------------------------------------------------------

- Deferred $9,016,914.47 principal+interest due June 30 to Aug 31, 2026.
- Minimum liquidity covenant reduced from $7.5M to $6.25M.
- Must enter definitive agreements for acceptable transaction by Aug 10, 2026.
- Prohibited from modifying compensation arrangements through Aug 31, 2026.
- Oaktree lenders agreed to these amendments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720893/000110465926089436/0001104659-26-089436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720893/000110465926089436/tm2622012d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-089436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer